# CathiportTM Clinical Efficacy and Safety Evaluation

> **NCT03198312** · NA · UNKNOWN · sponsor: **Shandong Branden Med.Device Co.,Ltd** · enrollment: 220 (actual)

## Conditions studied

- Cancer

## Interventions

- **DEVICE:** CathiportTM
- **DEVICE:** Implant Port

## Key facts

- **NCT ID:** NCT03198312
- **Lead sponsor:** Shandong Branden Med.Device Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10-20
- **Primary completion:** 2017-10-20
- **Final completion:** 2018-01-20
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2017-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03198312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03198312, "CathiportTM Clinical Efficacy and Safety Evaluation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03198312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*